A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

United States115th CongressS-3519Senate
Updated: Sep 27, 2018

Summary

Making Objective Drug Evidence Revisions for New Labeling Act or the MODERN Labeling Act This bill amends the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with authority to require updates to drug labeling to reflect new information relevant to the drug and its use.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

  2. Introduced in Senate

All available records shown.